Marker Therapeutics, Inc.

Monthly Archives: September 2017

TapImmune’s New CEO Shares the Potential of Cancer Immunotherapies

Peter Hoang loves being on the cutting-edge, and he believes Jacksonville-based TapImmune, Inc., which named him president and CEO Sept. 25, is there.
Read More

TapImmune Inc (NASDAQ:TPIV) Has Some Key Catalysts Coming Up

There are three trials that are really going to drive value for this company over the coming 24 months.
Read More

TapImmune Appoints Peter Hoang as President and Chief Executive Officer

TapImmune Welcomes Peter L. Hoang as President and Chief Executive Officer.
Read More

TapImmune (TPIV) Brings on Former Bellicum (BLCM) Exec as New CEO

TapImmune Inc. has a new chief executive officer. Peter Hoang, the former head of business development and strategy at Bellicum Pharmaceuticals, will take over for CEO Glynn Wilson, who has been reappointed to the position of chairman of the board of directors.
Read More